AP-101 is an investigational human-derived antibody that selectively targets the misfolded, toxic form of superoxide dismutase 1 (SOD1) to disrupt the progressive spread of ALS. The goal of this ...

Parent company of Fibe, Social Worth Technologies Ltd, filed for an IPO aiming to raise up to ₹750 crore. Proceeds will ...

It was the Elgin area's first quake in weeks and the fourth in South Carolina over the past 30 days. Only a few people ...

Somewhere among the White House’s fractured fairy tale about its reflecting pool faceplant, the ongoing whodunit masquerading ...

Social Worth Technologies, parent of digital lending platform Fibe, has filed draft IPO papers with Sebi for a fresh issue of ...

Whether you heat your home with natural gas or oil in the winter, use appliances, drive a gas-powered car, or give it all up ...

Goldman Sachs on Monday raised its price target on Robinhood to $121 from $108 while maintaining a Buy rating, citing record ...

As Europe searches for its next wave of industry 4.0 solutions, the tech startups driving it are increasingly warming up to ...

Detailed price information for United Microelectronics Corp ADR (UMC-N) from The Globe and Mail including charting and trades.

PrimeC is now FDA-cleared to enter Phase III development in ALS, as competition in the indication intensifies with several ...

Glen Parsons collecting ticks behind his home in 2019. First it was for search, but now it's for public awareness.

LONDON — Cellular therapy continues to advance treatment options for severe, refractory autoimmune diseases, according to newly released data presented at the European Alliance of Associations for ...